Movember Discovery Grants

Access to the Online Application: https://pccgrants.smartsimple.ca
Registration Deadline: February 15, 2017
Full Application Deadline: April 3, 2017
Funding Start Date: July 1, 2017smaller.jpg



Prostate Cancer Canada (PCC) is offering a limited number of Discovery Grants. While supporting novel research that aims to open up new lines of investigation, the goal is to support new and innovative studies in prostate cancer research.
The Discovery Grant program will:
  • allow both junior and more established investigators to pursue new avenues of exploration
  • allow applications from all areas of prostate cancer research
  • provide a budget of up to $200,000 per project that can be spent in up to two years of funding, thereby allowing some flexibility
  • fund applications that will have been evaluated by a rigorous peer-review process that assessed:
    • Innovation
    • Track record of investigator team
    • Feasibility of the proposed work
    • Potential impact on prostate cancer

The proposed research project must be in the area of prostate cancer and may address any of the broad areas of prostate cancer research, including but not limited to:
  • biomedical
  • clinical
  • population health
  • health services/economics

This opportunity is proudly funded by the Movember Foundation.


Discovery Grants that are based at institutions in New Brunswick and have met both scientific meritorious and financial cut-off requirements will be co-funded by PCC and the New Brunswick Health Research Foundation.

Links to:
Online application: https://pccgrants.smartsimple.ca
Program Description
Tipsheet for applicants


 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada Partners with Screw Cancer™

TORONTO, ON - Starting today, you can screw cancer and give hope in your local community by purchasing the Screw Cancer™ screwdriver in support of Prostate Cancer Canada.
More

Indy Cycling Challenge at Exhibition Place Announced to Support Prostate Cancer Canada

TORONTO (January 24, 2017) – Cycling enthusiasts have the opportunity to band together for a great cause while experiencing the Honda Indy Toronto like never before.
More

BRCA2 gene implicated in rare but lethal prostate cancer

January 9, 2017 – TORONTO, ON – Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer.
More


Click here for news archive